Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Malays Orthop J ; 16(1): 115-118, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35519518

ABSTRACT

This is a rare case report of medial femoral condyle fracture with irreducible incarcerated patella dislocation. Following the literature search, only a few cases have been reported in the literature. In this case, the patient had undergone open reduction and screw fixation of the femoral condyle, augmented with a distal femoral locking plate (LCP). Postoperatively patient was immobilised with an above knee backslab for a month. After removing the backslab, physiotherapy was commenced to improve the range of motion and strengthening the quadriceps muscle. After 18 months of follow-up, the patient recovered well with a satisfactory bone union, no episode of patella dislocation, full weight bearing with an acceptable range of motion of his left knee about 0° to 90°. He could squat, climb stairs, and walk without any walking aid and returned to work as a food deliverer.

2.
Zhonghua Gan Zang Bing Za Zhi ; 27(2): 123-127, 2019 Feb 20.
Article in Chinese | MEDLINE | ID: mdl-30818917

ABSTRACT

Objective: To evaluate the real-world safety and curative effect of ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in non-cirrhotic or compensated cirrhotic patients. Methods: A real-world research method was adopted, and the research was conducted at three medical centers of mainland China. Non- cirrhotic or compensated cirrhotic patients with HCV genotype 1b infection who were initially treated with IFN/PEG-IFN-alpha combined with ribavirin, and ombitasvir combined with dasabuvir for 8 or 12 weeks were taken. Sustained virological response (SVR) and the incidence of adverse events during treatment and follow-up were evaluated after 12 weeks of drug withdrawal at OBV/PTV/r 25/150/100mg once daily and DSV 250mg, twice daily. Median and range were used for description of non-normally distributed data. Results: 80 cases of GT1b were included in this study. Of these 88.8% (71/80) were newly diagnosed, 12.5% (10/80) were compensated cirrhotic, 97.5% (78/80) received 12 weeks treatment, and 2.5% (2/80) received 8 weeks treatment. The rate of HCV RNA negative at EOT (end of treatment) was 100% (64/64). A total of 67 patients completed the treatment within 12 weeks, and 43 patients returned to the hospital for further consultations, and SVR12 was 100%(43/43). No patient discontinued the drugs because of an adverse event during treatment. Conclusion: In the real world, Ombitasvir combined with dasabuvir for the treatment of chronic hepatitis C 1b genotype infection in China has 100% rates of EOT and SVR12 with well- tolerability and safety.


Subject(s)
Antiviral Agents/therapeutic use , Hepacivirus/genetics , Hepatitis C, Chronic/drug therapy , Ribavirin/therapeutic use , 2-Naphthylamine , Anilides , Carbamates , China/epidemiology , Cyclopropanes , Drug Therapy, Combination , Genotype , Hepacivirus/isolation & purification , Hepatitis C, Chronic/epidemiology , Hepatitis C, Chronic/genetics , Humans , Lactams, Macrocyclic , Macrocyclic Compounds , Proline/analogs & derivatives , Ritonavir , Sulfonamides , Uracil/analogs & derivatives , Valine
3.
Zhonghua Gan Zang Bing Za Zhi ; 26(12): 894-897, 2018 Dec 20.
Article in Chinese | MEDLINE | ID: mdl-30669780

ABSTRACT

The clinical phenotype of genetic liver disease is significantly different. Although the incidence of disease is low, because of the wide spectrum of diseases, the overall affected population is not rare. Therefore, clinical concern is a matter of alarm. Additionally, these diseases rarity in clinical practice has covered the recognition, causing increased problem of clinical misdiagnosis. In accordance with the problems encountered in clinical practice of our hospital, we explore the clinical diagnosis of genetic liver disease.


Subject(s)
Genetic Predisposition to Disease , Liver Diseases/genetics , Heredity , Humans , Liver Diseases/diagnosis , Phenotype , Predictive Value of Tests
4.
Science ; 349(6246): 400-4, 2015 Jul 24.
Article in English | MEDLINE | ID: mdl-26206929

ABSTRACT

Superelastic conducting fibers with improved properties and functionalities are needed for diverse applications. Here we report the fabrication of highly stretchable (up to 1320%) sheath-core conducting fibers created by wrapping carbon nanotube sheets oriented in the fiber direction on stretched rubber fiber cores. The resulting structure exhibited distinct short- and long-period sheath buckling that occurred reversibly out of phase in the axial and belt directions, enabling a resistance change of less than 5% for a 1000% stretch. By including other rubber and carbon nanotube sheath layers, we demonstrated strain sensors generating an 860% capacitance change and electrically powered torsional muscles operating reversibly by a coupled tension-to-torsion actuation mechanism. Using theory, we quantitatively explain the complementary effects of an increase in muscle length and a large positive Poisson's ratio on torsional actuation and electronic properties.


Subject(s)
Elastic Tissue , Electronics , Muscle, Skeletal , Nanotubes, Carbon , Elasticity , Electric Capacitance , Torsion, Mechanical
5.
Intern Med J ; 45(6): 672-6, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26059880

ABSTRACT

Here we report the case of a 69-year-old Chinese Han woman who presented with liver cirrhosis, diabetes mellitus, skin hyperpigmentation, hyperferritinaemia and high transferrin saturation. Subsequent genetic analyses identified a novel heterozygous mutation (p.Cys326Phe) in the SLC40A1 gene. This is the first report regarding a SLC40A1 mutation in the Chinese Han population and provides novel clinical evidence for the importance of p.Cys326 in SLC40A1 gene function.


Subject(s)
Cation Transport Proteins/deficiency , Hemochromatosis/diagnosis , Hemochromatosis/genetics , Mutation/genetics , Aged , Amino Acid Sequence , Cation Transport Proteins/genetics , Female , Humans , Molecular Sequence Data , Pedigree , Protein Structure, Secondary
6.
J Int Med Res ; 36(4): 728-33, 2008.
Article in English | MEDLINE | ID: mdl-18652769

ABSTRACT

The interaction of CD40 with CD154 is a pivotal trigger of immune cascade-inducing acute liver failure, however its clinical significance has not been well studied. The present study aimed to investigate the clinical implications of serum-soluble CD154 (sCD154) levels and the expression of CD40 on monocytes in patients with fulminant hepatic failure (FHF). The results showed that serum sCD154 levels and CD40 expression on monocytes were significantly higher in FHF patients than in acute hepatitis (AH) patients and healthy controls, and were also significantly higher in FHF patients who died, compared with those who survived. We conclude that high serum levels of sCD154 may be linked to fatal outcome in patients with severe liver injury and may be a valuable prognostic marker for survival in patients with FHF.


Subject(s)
CD40 Ligand/blood , Liver Failure, Acute/blood , Liver Failure, Acute/immunology , Animals , CD40 Ligand/immunology , Female , Humans , Liver Failure, Acute/diagnosis , Male , Monocytes/cytology , Monocytes/metabolism , Predictive Value of Tests , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...